UK Companies House feature
VIRIDIAN PHARMA LIMITED
Profile
- Company number
- 04398894
- Status
- Active
- Incorporation
- 2002-03-20
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“To support the directors' assessment of the Company as a going concern, the Company undertakes regular forecasting of financial performance and cash flows. The approach to forecasting considers sensitivities around long term trading assumptions and the availability of funding and continued support from fellow Group entities. The directors have considered the financial position of the company at 31 December 2024 and the projected cash flows and financial performance of the company for the 12 months from the date of approval of these financial statements. The directors have also taken action to ensure that appropriate cash resources are available to fund the company's operations. Therefore, the directors consider, after making appropriate enquiries, that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
5 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| RUYANT, Foucauld | Secretary | 2024-09-30 | — | — |
| DE ULTRA DE SOUSA BARCELOS, Bruno | Director | 2023-01-17 | Aug 1973 | Portuguese |
| LASSERRE, Xavier Pierre Christian | Director | 2023-06-26 | Apr 1972 | French |
| MEHRAI, Alexander | Director | 2026-03-30 | Jun 1975 | British |
| RUYANT, Foucauld | Director | 2024-09-30 | Oct 1975 | French |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LANNING, Michael George | Secretary | 2002-05-20 | 2002-10-04 |
| SMITH, Gillian Dawn | Secretary | 2002-10-04 | 2016-07-01 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2002-03-20 | 2002-05-20 |
| BOVOLENTA, Andrea | Director | 2024-03-01 | 2024-06-05 |
| CLARK, Michael Leslie | Director | 2016-07-01 | 2017-02-28 |
| DELUARD, Bertrand | Director | 2019-03-11 | 2022-09-13 |
| GROVER, Jason | Director | 2016-07-01 | 2017-02-28 |
| HARRIS, Michael Christopher James | Director | 2016-07-01 | 2019-01-01 |
| JOANNESSE, Roseline Georgette | Director | 2017-02-28 | 2019-03-11 |
| LANNING, Michael George | Director | 2002-05-20 | 2016-07-01 |
| MONIN, Jean Bernard Claude | Director | 2022-11-01 | 2023-06-26 |
| POW, David | Director | 2002-05-20 | 2002-05-21 |
| ROCKLEY, Timothy Joseph | Director | 2002-10-04 | 2016-07-01 |
| SCHMIDT, Emmanuel | Director | 2019-03-11 | 2022-12-31 |
| SMITH, Julian Craig | Director | 2002-10-04 | 2016-07-01 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 2002-03-20 | 2002-05-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Orphea Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2023-08-30 | Active |
| Macarthys Laboratories Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors, Significant influence | 2016-07-01 | Ceased 2023-08-30 |
Filing timeline
Last 20 of 112 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-31 | AP01 | officers | appoint person director company with name date |
| 2025-10-28 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-09-22 | AA | accounts | accounts with accounts type full |
| 2024-12-12 | AA | accounts | accounts with accounts type full |
| 2024-10-30 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-10-17 | AP03 | officers | appoint person secretary company with name date |
| 2024-10-17 | AP01 | officers | appoint person director company with name date |
| 2024-10-17 | TM01 | officers | termination director company with name termination date |
| 2024-03-01 | AP01 | officers | appoint person director company with name date |
| 2023-10-30 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-10-03 | AA | accounts | accounts with accounts type dormant |
| 2023-09-01 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2023-09-01 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2023-07-10 | AP01 | officers | appoint person director company with name date |
| 2023-07-10 | TM01 | officers | termination director company with name termination date |
| 2023-05-10 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-01-27 | AP01 | officers | appoint person director company with name date |
| 2023-01-27 | TM01 | officers | termination director company with name termination date |
| 2022-12-07 | AP01 | officers | appoint person director company with name date |
| 2022-09-23 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory